What is Tepezza team like?

Quote



You have not seen metrics overload until you have seen what we are doing in the dynasty. It's something to behold. We don't even know our market share or if we are growing or declining. We just enter calls, check alerts, and work on ACT3 slides.
 










There’s a reason why all the Asthma folks threw a huge keg party when TK left…and she wasn’t invited. She’s the worst of them all, leads by intimidation and has bred some of the worst so-called leaders at Amgen…CH, EP to name a few-both of which come with their own set of HR history.
 


anonymous said:
There’s a reason why all the Asthma folks threw a huge keg party when TK left…and she wasn’t invited. She’s the worst of them all, leads by intimidation and has bred some of the worst so-called leaders at Amgen…CH, EP to name a few-both of which come with their own set of HR history.
Click to expand...
I believe it. Watching her and the Tepezza priorities at the NSM makes me want to leave. And I'm not even on the Tepezza team. Bad news over there. And I'm sure it will eventually spread to all of us. That lady has no right to be anywhere near a rare disease drug. It was obvious that she was utterly clueless.
 
















Can’t wait to make less for the same effort. This IC plan is not good. The fact that they didn’t even think about going back and looking at Q1 when many people struggled is a slap in the face. Thank you to those who brought it up! Just goes to show how much they just don’t care.
And the contest doesn’t include non tiered?! Isn’t the whole push breadth and depth?
 






anonymous said:
Why
Click to expand...
Why?
They restructured, and let go the SMLs, ASDs, and some SAMs 6 months ago. Only to realize they screwed up and now need to hire those positions back. (But those were mostly Horizon people so they had to get rid of them bcuz Amgen people or new people who have zero experience in rare disease are so much better… insert eye roll here).
Implementing a new IC where 20-25% of the salesforce won’t make bonus because they overshot goals and raised the threshold to qualify. But I guess that doesn’t really matter because Amgen made their money either way am I right?
Oh and let’s not forget when asked if they are going to go back and look at Q1 and adjust they claim “hadn’t thought about it”.
So…..now they’re going expand a salesforce that isn’t super effective, maybe now will be. And make the OSAM territories they made too big to manage smaller again.(because accounts will love that, and that’s not disruptive at all).
All while firing the “leader” they hired 6 months ago who screwed up q4 and q1 in the first place.
Did I leave anything out?
 


I liked the old days, when I was in the field all day long with little to distract me.

I'm now on 3-4 calls per week, have special projects to complete, and my manager is with me all the time. I bet I average 10 calls less per week or 40 a month.

Amgen's activity focus is miserable but all consuming
 



Write your reply...
Top Bottom
Back
Quote